We analysed the relationship between liver cancer immune scores and TP53, AXIN1, and TP53 gene mutations, and found that StromalScore was significantly smaller in the TP53 mutant group than in the wild group (P<0.05). The gene discussed is AXIN1; the disease is liver cancer.